SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950005-07-000005
Filing Date
2007-01-16
Accepted
2007-01-16 12:00:17
Documents
1
Group Members
ALIX MARDUELALTA BIOPHARMA MANAGEMENT III, LLCALTA BIOPHARMA PARTNERS III GMBH & CO. BETEILIGUNGS KGALTA BIOPHARMA PARTNERS III, L.P.ALTA EMBARCADERO BIOPHARMA PARTNERS III, LLCALTA PARTNERS III, INC.EDWARD HURWITZEDWARD PENHOETFARAH CHAMPSIJEAN DELEAGE

Document Format Files

Seq Description Document Type Size
1 SCHEUDLE 13G p2000813g.htm SC 13G 240864
  Complete submission text file 0000950005-07-000005.txt   243325
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 07531151
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 415-362-4022
Alta Partners III, Inc. (Filed by) CIK: 0001341610 (see all company filings)

IRS No.: 201317397 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G